Glucagon News and Research

RSS
On-line journal Diabetic Hypoglycemia calls for greater understanding and taking control of diabetes

On-line journal Diabetic Hypoglycemia calls for greater understanding and taking control of diabetes

Emisphere Technologies' key product developments and financial results for the third quarter of 2009

Emisphere Technologies' key product developments and financial results for the third quarter of 2009

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

Eat slowly to avoid overeating

Eat slowly to avoid overeating

Roche discloses the results of first Phase III clinical study using Taspoglutide

Roche discloses the results of first Phase III clinical study using Taspoglutide

Oral GLP-1 Analog approved for human clinical trial

Oral GLP-1 Analog approved for human clinical trial

Grant awarded to two researchers to study the role of GLP-1 in people at risk for or with diabetes

Grant awarded to two researchers to study the role of GLP-1 in people at risk for or with diabetes

Paper discussing the mechanism of the selective TGR5 agonist INT-777 published in Cell Metabolism

Paper discussing the mechanism of the selective TGR5 agonist INT-777 published in Cell Metabolism

More insulin-producing cells from a single transcription factor switch

More insulin-producing cells from a single transcription factor switch

NDA for Exenatide once weekly accepted for FDA review

NDA for Exenatide once weekly accepted for FDA review

Research finds insulin plays a key role in suppressing levels of glucagon

Research finds insulin plays a key role in suppressing levels of glucagon

Why low GI diet makes you feel full

Why low GI diet makes you feel full

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

Leptin shows potential for type 1 diabetes

Leptin shows potential for type 1 diabetes

Three new genetic variations that increase the risk of obesity

Three new genetic variations that increase the risk of obesity

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

Once a week treatment for type 2 diabetes in the pipeline

Once a week treatment for type 2 diabetes in the pipeline

UT Southwestern scientists discover leptin can also aid type 1 diabetics

UT Southwestern scientists discover leptin can also aid type 1 diabetics

Discovery of new signal pathway important to diabetes research

Discovery of new signal pathway important to diabetes research